Welcome to our dedicated page for Flora Growth SEC filings (Ticker: FLGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Flora Growth Corp. (NASDAQ: FLGC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as it transitions toward a rebrand as ZeroStack and emphasizes its role as a decentralized AI treasury company and global pharmaceutical distributor. These filings, drawn from the SEC’s EDGAR system, document Flora’s corporate actions, financing arrangements and governance decisions in detail.
Investors can review Form 8-K current reports describing material events such as the 1-for-39 share consolidation, the company’s regaining of compliance with Nasdaq’s minimum bid price requirement, and multiple private placement transactions involving common shares, pre-funded warrants, common share purchase warrants and convertible notes. Specific 8-K filings outline cash and token-based private placements, a convertible note with DeFi Development Corp., a convertible note arrangement with Zero Gravity Labs Inc., and the company’s plans to use proceeds and tokens to further its digital asset treasury strategy linked to $0G.
The page also includes proxy materials such as the DEF 14A definitive proxy statement for the 2025 Special Meeting of Shareholders. That document details proposals for the name change to ZeroStack Corp., the creation of a new class of preferred shares, amendments to the 2022 Incentive Compensation Plan, approvals for option grants, approvals related to private placement issuances, authority for a forward share split, and potential adjournments. Additional filings describe amendments to the 2022 Incentive Compensation Plan and the repricing and vesting changes for certain stock appreciation rights.
Through Stock Titan, these SEC filings are updated in real time from EDGAR and are paired with AI-powered summaries that highlight key terms, capital structure changes, and treasury strategy disclosures. Users can quickly understand how Flora structures its digital asset-related financings, how it manages its Nasdaq listing requirements, and how shareholder approvals shape its evolution into ZeroStack. Forms such as 10-K and 10-Q, when available, complement the 8-K and proxy materials by providing broader financial and operational context.